bpc-157 legal status us 2026 fda July Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety FDA to weigh easing limits

The theory is that the bodys signaling pathways reach their limit at low concentrations regardless of body size

References Huang T, Zhang K, Sun L, et al

If BPC-157 was purchased today, the patent would likely expire in 2033 before the phase 1-2-3 trials would be completed, at which point all the generic manufacturers would be able to push the product on the back of all the hard work a pharmaceutical company can do (Im not sure if FDA approval would push the expiration of the patent back, but even then it would not be so financial lucrative)

Originally studied for its gut-healing properties, researchers soon discovered its potential for repairing and strengthening muscles, tendons, and ligaments